Provided by Tiger Fintech (Singapore) Pte. Ltd.

CDT Equity

4.18
+0.390010.29%
Post-market: 4.440.2600+6.22%17:50 EDT
Volume:316.33K
Turnover:1.29M
Market Cap:5.65M
PE:-0.01
High:4.31
Open:3.76
Low:3.67
Close:3.79
52wk High:2,198.40
52wk Low:3.40
Shares:1.35M
Float Shares:1.10M
Volume Ratio:0.19
T/O Rate:28.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-419.1707
EPS(LYR):-2,463.6889
ROE:--
ROA:-198.03%
PB:1.60
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
CDT Equity
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
- -
Office Location:
4581 Tamiami Trail North,Suite 200,Naples,Florida,United States
Zip Code:
34103
Fax:
- -
Introduction:
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Directors

Name
Position
Andrew Regan
Director and Chief Executive Officer
Freda Lewis Hall
Chairman of the Board
Chele Chiavacci Farley
Independent Director
James Bligh
Chief Financial Officer, Director
Simon Fry
Independent Director

Shareholders

Name
Position
Andrew Regan
Director and Chief Executive Officer
James Bligh
Chief Financial Officer, Director